Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct:87:106424.
doi: 10.1016/j.ijscr.2021.106424. Epub 2021 Sep 20.

Hepatic hemangioendothelioma - A rare case report

Affiliations

Hepatic hemangioendothelioma - A rare case report

Kaleem Ullah et al. Int J Surg Case Rep. 2021 Oct.

Abstract

Introduction and importance: Hepatic hemangioendothelioma (HHE) is a very rare mild-moderate malignant tumor of the hepatic vascular endothelium. The etiology is yet not fully understood. Patients can be asymptomatic or may present with non-specific symptoms or hepatic insufficiency. CT and MRI scans show various radiographic features but a definitive diagnosis can be made with histological analysis and immunohistochemistry. Here we report a case of a patient who presented with a non-resectable disease for which living donor liver transplantation was done.

Case presentation: A 19-year-old female patient presented with intermittent moderate dull pain in the right hypochondrium for 9 months. Examination revealed mild tender hepatomegaly. On abdominal ultrasound, two hypoechoic lesions were noted in both lobes of the liver that were confirmed on CT scan. Histologic examination of the ultrasound-guided fine-needle aspiration cytology of the voluminous right lobe lesion clinched the diagnosis of HHE. The patient underwent successful living donor liver transplantation due to the multifocal bi-lobar nature of the lesions. At 8 months follow up, she is fine and doing well.

Conclusion: HHE is a very rare mild-moderate malignant tumor of hepatic vascular origin. Resection is the preferable treatment option in patients with resectable disease. However, liver transplantation has become the treatment of choice for patients with non-resectable multifocal and bi-lobar lesions. The long-term outcome of this malignancy is not fully known and there is a need for long-term follow-up studies to determine the actual recurrence rate of this disease.

Keywords: Diagnostic imaging; Hepatic hemangioendothelioma (HHE); Liver transplantation (LT); Resection; Vascular tumor.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Fig. 1
Fig. 1
CT scan liver showing two hypodense lesions in the arterial phase.
Fig. 2
Fig. 2
a Low power b Medium power.

References

    1. Mehrabi A., Kashfi A., Fonouni H., Schemmer P., Schmied B.M., Hallscheidt P., Schirmacher P., Weitz J., Friess H., Buchler M.W., Schmidt J. Primary malignant hepatic epithelioid heman¬gioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer. 2006;107:2108–2121. - PubMed
    1. Liu Y.I., Brown S.S., Elihu A., Bonham C.A., Concepcion W., Longacre T.A. Hepatic epithelioid hemangioendothelioma. Dig. Dis. Sci. 2011 Feb;56(2):303–306. - PubMed
    1. Weiss S.W., Enzinger F.M. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer. 1982;50:970–981. - PubMed
    1. for the SCARE Group. Agha R.A., Franchi T., Sohrabi C., Mathew G. The SCARE 2020 guideline: updating consensus Surgical CAse REport (SCARE) guidelines. Int. J. Surg. 2020;84:226–230. - PubMed
    1. Nudo C.G., Yoshida E.M., Bain V.G., Marleau D., Wong P., Marotta P.J. Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience. Can. J. Gastroenterol. 2008 Oct;22(10):821–824. - PMC - PubMed